$PYPD: What history says after milestone/FDA-timeline updates
How PYPD has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | -3.5% |
| May 2026 | -7.5% |
| Nov 2025 | -0.3% |
| May 2025 | +7.0% |
| Feb 2025 | +2.9% |
Median absolute move 3.5% · higher 2 of 5 · n=5
PolyPid Ltd. Ordinary Shares ($PYPD) outlined a strong financial position and key milestones ahead of FDA approval for DPLX100, targeting an early 2027 launch.
How $PYPD has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | -3.5% |
| May 2026 | -7.5% |
| Nov 2025 | -0.3% |
| May 2025 | +7.0% |
| Feb 2025 | +2.9% |
Base rate (n=5):
- Median absolute next-day move: 3.5%
- Next-day higher: 2 of 5
- Biggest next-day up: +7.0%
- Biggest next-day down: -7.5%